Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$0.59 - $2.24 $63,649 - $241,651
-107,880 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$1.76 - $2.46 $3,039 - $4,248
-1,727 Reduced 1.58%
107,880 $243,000
Q1 2020

May 15, 2020

BUY
$1.95 - $2.9 $181,059 - $269,267
92,851 Added 554.14%
109,607 $236,000
Q4 2019

Feb 14, 2020

SELL
$2.5 - $3.08 $7,922 - $9,760
-3,169 Reduced 15.9%
16,756 $47,000
Q2 2019

Aug 14, 2019

SELL
$2.77 - $4.5 $207 - $337
-75 Reduced 0.38%
19,925 $58,000
Q3 2018

Nov 15, 2018

BUY
$4.17 - $4.89 $83,400 - $97,800
20,000 New
20,000 $92,000

Others Institutions Holding NAOV

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About NanoVibronix, Inc.


  • Ticker NAOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,997,800
  • Market Cap $16.2M
  • Description
  • NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...
More about NAOV
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.